Navana Pharmaceuticals (DHA:NAVANAPHAR) EPS (Basic) : BDT (TTM As of . 20)

View and export this data going back to 2022. Start your Free Trial

What is Navana Pharmaceuticals EPS (Basic)?

Navana Pharmaceuticals's basic earnings per share (Basic EPS) for the six months ended in . 20 was BDT0.00. Navana Pharmaceuticals does not have enough years/quarters to calculate its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in . 20.

Navana Pharmaceuticals's EPS (Diluted) for the six months ended in . 20 was BDT0.00. Navana Pharmaceuticals does not have enough years/quarters to calculate its EPS (Diluted) for the trailing twelve months (TTM) ended in . 20.

Navana Pharmaceuticals's EPS without NRI for the six months ended in . 20 was BDT0.00. Navana Pharmaceuticals does not have enough years/quarters to calculate its EPS without NRI for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Navana Pharmaceuticals EPS (Basic) Historical Data

The historical data trend for Navana Pharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navana Pharmaceuticals EPS (Basic) Chart

Navana Pharmaceuticals Annual Data

Trend

EPS (Basic)

Navana Pharmaceuticals Semi-Annual Data

EPS (Basic)

Navana Pharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Navana Pharmaceuticals's Basic EPS for the fiscal year that ended in . 20 is calculated as

Basic EPS (A: . 20 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(	-	)	/	0
	=

Navana Pharmaceuticals's Basic EPS for the quarter that ended in . 20 is calculated as

Basic EPS (Q: . 20 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(	-	)	/	0
	=

Navana Pharmaceuticals (DHA:NAVANAPHAR) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Navana Pharmaceuticals EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Navana Pharmaceuticals's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Navana Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Navana Pharmaceuticals PLC (DHA:NAVANAPHAR) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Road 4, House 99, Block B, Banani, Dhaka, BGD, 1213

Website

https://www.navanapharma.com

Navana Pharmaceuticals PLC operates its business under two divisions namely Veterinary Division and Human Health Division. Veterinary Division manufactures and markets high-quality veterinary medicine and feed supplements for different segments including poultry, dairy and aqua products. Human Health Division operates its manufacturing facilities in strict compliance with WHO cGMP guidelines for the production of tablets, capsules, oral liquids, ampoules, dry powder vials, powder for suspension, eye drops, creams and ointments.

Navana Pharmaceuticals Headlines

No Headlines